Enrollment of older patients in cancer treatment trials in Canada: Why is age a barrier?

Journal of Clinical Oncology

Volumn 21, Issue 8, 2003, Pages 1618-1623

  Yee, Karen W L ^a   Pater, Joseph L ^a   Pho, Lam ^a   Zee, Benny ^a   Siu, Lillian L ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; CANADA; CONTROLLED STUDY; ELDERLY CARE; EVALUATION RESEARCH; HUMAN; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MULTIPLE MYELOMA; POPULATION RECOVERY; PRIORITY JOURNAL; PUBLICATION; REGISTRATION; UNITED STATES; AGE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; EMPIRICAL APPROACH; FEMALE; HEALTH CARE DELIVERY; MALE; NEOPLASM; PATIENT SELECTION; STATISTICS;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

AGE FACTORS; AGED; CANADA; CLINICAL TRIALS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALE; NEOPLASMS; PATIENT SELECTION; UNITED STATES;

EID: 0038518557     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2003.12.044     Document Type: Article

References (48)

1. National Cancer Institute of Canada: Canadian Cancer Statistics 2000. Toronto, Ontario, Canada, National Cancer Institute of Canada, 2000
2. Goodwin JS, Hunt WC, Humble CG: Cancer treatment protocols: Who gets chosen? Arch Intern Med 148:2258-2260, 1988
3. Trimble EL, Carter CL, Cain D, et al: Representation of older patients in cancer treatment trials. Cancer 74:2208-2214, 1994
4. Hunter CP, Frelick RW, Feldman AR, et al: Selection factors in clinical trials: Results from the community clinical oncology program physician's patient log. Cancer Treat Rep 71:559-565, 1987
5. Hutchins LF, Unger JM, Crowley JJ, et al: Underrepresentation of patients 65 years of age or older in cancer treatment trials. N Engl J Med 341:2061-2067, 1999
6. Marlin SM, Pater JL, Myles JD: Characteristics of National Cancer Institute of Canada Clinical Trials Group participants (1974-1993). Clin Invest Med 19:50a, 1996 (suppl, abstr 50)
7. Shustik C, Belch A, Meyer R, et al: Melphalan-dexamethasone is not superior to melphalan-prednisone as induction therapy in multiple myeloma. Proc Am Soc Clin Oncol 20:298a, 2001 (abstr 1191)
8. Bergman L, Kluck HM, van Leeuween FE, et al: The influence of age on treatment choice and survival of elderly breast cancer patients in south-eastern Netherlands: A population-based study. Eur J Cancer 28a:1475-1480, 1992
9. Busch E, Kemeny M, Fremgen A, et al: Patterns of breast cancer care in the elderly. Cancer 78:101-111, 1996
10. Goodwin JS, Samet JM, Hurt WC: Determinants of survival in older cancer patients. J Natl Cancer Inst 88:1031-1037, 1996
11. Brown ML: Cancer patient care in clinical trials sponsored by the National Cancer Institute: What does it cost? J Natl Cancer Inst 91:818-819, 1999
12. Dillabough ESG: An ethical approach to health care reform in Canada: A comparison of the Canadian and American health care systems. Health Law Can 18:75-95, 1998
13. Bennett CL, Stinson TJ, Vogel V, et al: Evaluating the financial impact of clinical trials in oncology: Results from a pilot study from the Association of American Cancer Institute/Northwestern University Clinical Trials Costs and Charges Project. J Clin Oncol 18:2805-2810, 2000
14. Benson AB IH, Pregler JP, Bean JA, et al: Oncologists' reluctance to accrue patients onto clinical trials: An Illinois Cancer Center study. J Clin Oncol 9:2067-2075, 1991
15. Begg CB, Zelen M, Carbone PP, et al: Cooperative groups and community hospitals: Measurement of impact in the community hospitals. Cancer 52:1760-1767, 1983
16. Martin JF, Henderson WG, Zacharski LR, et al: Accrual of patients into a multihospital cancer clinical trial and its implications on planning future studies. Am J Clin Oncol 7:173-182, 1984
17. McCusker J, Wax A, Bennett JM: Cancer patients accessions into clinical trials: A pilot investigation into some patient and physician determinants of entry. Am J Clin Oncol 5:227-236, 1982
18. Lee JY, Marks JE, Simpson JR: Recruitment of patients to cooperative group clinical trials. Cancer Clin Trials 3:381-384, 1980
19. Kornblith AB, Kemeny M, Peterson B, et al: Survey of oncologists' perception of barriers to accrual of older patients with breast carcinoma to clinical trials. Cancer 95:989-996, 2002
20. Comis RL, Aldige CR, Stovall EL, et al: A quantitative survey of oublie attitudes towards cancer clinical trials: Coalition of National Cancer Cooperative Groups. Proc Am Soc Clin Oncol 19:451a, 2000 (abstr 1769)
21. Finn R: Surveys identify barriers to participation in clinical trials. J Natl Cancer Inst 92:1556-1558, 2000
22. Newcomb PA, Carbone PP: Cancer treatment and age: Patient perspectives. J Natl Cancer Inst 85:1580-1584, 1993
23. Lara PN Jr, Higdon R, Lim N, et al: Prospective evaluation of cancer clinical trial accrual patterns: Identifying potential barriers to enrollment. J Clin Oncol 19:1728-1733, 2001
24. Lichtman SM, Skirvin JA: Pharmacology of antineoplastic agents in older cancer patients. Oncology 14:1743-1755, 2000
25. Zauber NP, Zauber AG: Hematologic data of healthy very old people. J Am Med Assoc 257:2181-2184, 1987
26. Chatta GS, Price TH, Dale DC: Aging and the neutrophil response to r-metHuG-CSF in healthy young and elderly individuals. Blood 80:290a, 1992 (suppl, abstr 1152)
27. Wei JY: Age and the cardiovascular system. N Engl J Med 327:1735-1739, 1992
28. Meyer BR: Renal function in aging. J Am Geriatr Soc 37:791-800, 1989
29. Zaugg M, Lucchinetti E: Respiratory function in the elderly. Anesthesiol Clin North America 18:47-58, 2000
30. Rossi A, Ganassini A, Tantucci C, et al: Aging and the respiratory system. Aging 8:143-161, 1996
31. Iber FL, Murphy PA, Connor ES: Age-related changes in the gastrointestinal system: Effects on drug therapy. Drugs Aging 5:34-48, 1994
32. Yancik R, Havlik RJ, Wesley MN, et al: Cancer and comorbidity in older patients: A descriptive profile. Ann Epidemiol 6:399-412, 1996
33. Satariano WA, Ragland DR: The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 120:104-110, 1994
34. Begg CB, Cohen JL, Ellerton J: Are the elderly predisposed to toxicity from cancer chemotherapy? An investigation using data from the Eastern Cooperative Oncology Group. Cancer Clin Trials 3:369-374, 1980
35. Christman K, Muss HB, Case LD, et al: Chemotherapy of metastatic breast cancer in the elderly: The Piedmont Oncology Association experience. J Am Med Assoc 268:57-62, 1992
36. Giovanazzi-Banon S, Rademaker A, Lai G, et al: Treatment tolerance of elderly cancer patients entered onto phase II clinical trials: An Illinois Cancer Center study. J Clin Oncol 12:2447-2452, 1994
37. Siu LL, Shepherd FA, Murray N, et al: Influence of age on the treatment of limited-stage small-cell lung cancer. J Clin Oncol 14:821-828, 1996
38. Johnson PRE: Acute myeloid leukemia in the elderly: Biology and treatment. Br J Haematol 83:1-6, 1993
39. Weick JK, Kopecky KJ, Appelbaum FR, et al: A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: A Southwest Oncology Group Study. Blood 88:2841-2851, 1996
40. Sargent DJ, Goldberg RM, Jacobson SD, et al: A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 345:1091-1097, 2001
41. Popescu RA, Norman A, Ross PJ, et al: Adjuvant or palliative chemotherapy for colorectal cancer patients 70 years or older. J Clin Oncol 17:2412-2418, 1999
42. Gelman RS, Taylor IV SG: Cyclophosphamide, methotrexate, and 5-tluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: The elimination of age trends in toxicity by using doses based on creatinine clearance. J Clin Oncol 2:1404-1413, 1984
43. Bonadonna G, Valagussa P: Dose-response effect of adjuvant chemotherapy in breast cancer. N Engl J Med 304:10-15, 1981
44. Sonneveld P, de Ridder M, Van Der Lelie H, et al: Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy. J Clin Oncol 13:2530-2539, 1995
45. Extermann M, Balducci L, Lyman GH: What threshold for adjuvant therapy in older breast cancer patients? J Clin Oncol 18:1709-1717, 2000
46. Balducci L, Yates J: General guidelines for the management of older patients with cancer: Senior Adult Care Task Force. Oncology 14:221-227, 2000
47. Yancik R, Ganz PA, Varricchio CG, et al: Perspectives on comorbidity and cancer in older patients: Approaches to expand the knowledge base. J Clin Oncol 19:1147-1151, 2001
48. Castellucci L: Better fundamentals, not 'razzle dazzle,' needed in cancer research on the elderly. J Natl Cancer Inst 91:14-16, 1999